Author: openjargon

The Harvey Norman Holdings Ltd (ASX: HVN) share price is in focus today after the company reported a 4.9% increase in statutory profit before tax to $790.29 million and announced a fully-franked final dividend of 13.0 cents per share.

What did Harvey Norman report?

• Total system sales revenue up 3.1% to $9.64 billion
• Earnings before interest, tax, depreciation & amortisation (EBITDA) rose 5.0% to $1.18 billion
• Statutory profit before tax increased 4.9% to $790.29 million
• Underlying profit before tax (excl. AASB 16, property revals, penalty) up 10.9% to $654.69 million
• Basic earnings per share grew 2.0% to 42.41 cents
• Fully-franked dividend lifted 3.8% to 27.5 cents per share for FY26

What else do investors need to know?

The company highlighted strong performance from its international operations, with overseas company-operated retail profit before tax jumping 23.4% to $135.72 million. Harvey Norman continued its international expansion, particularly in the UK, where its platform is being scaled for long-term growth.

Asset strength remains a key feature, with total assets increasing 5.7% to $8.85 billion. Operating cash flows were robust at $537.22 million, underpinning ongoing investments, dividend payments, and future initiatives.

What did Harvey Norman management say?

The company’s chair, Gerry Harvey, commented:

FY26 delivered growth in operating earnings, continued international expansion and strong franchise profitability. With total assets approaching $9 billion, net assets approaching $5 billion, substantial property ownership and low gearing, we remain well positioned to deliver long-term sustainable growth for our shareholders.

What’s next for Harvey Norman?

Harvey Norman is focused on leveraging its growing international presence, especially in established markets like New Zealand, Asia, and Europe. Management expects positive momentum to continue as the company opens new stores, invests in Next Gen-AI product categories, and maintains attention to cost management.

With a strong asset-backed balance sheet and conservative gearing, the business aims to fund further expansions while supporting long-term value creation for shareholders.

Harvey Norman share price snapshot

The Harvey Norman share price is underperforming the S&P/ASX 200 index (ASX: XJO) with a decline of around 27% over the past 12 months.

View Original Announcement

The post Harvey Norman lifts profit and dividend in FY26 earnings result appeared first on The Motley Fool Australia.

More reading

• How much passive income can I earn off a $900,000 superannuation balance?
• Have these ASX 200 shares now fallen too far to ignore the value?
• These ASX 200 shares could generate $10,000 per year in passive income
• How to build a $100,000 passive income with ASX shares
• My top Australian passive income picks this month

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Harvey Norman. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The WAM Capital Ltd (ASX: WAM) share price is in focus today after reporting a 10.5% decline in its investment portfolio for FY2026 and announcing a maintained final dividend of 7.75 cents per share, partially franked at 60%.

What did WAM Capital report?

• Full year FY2026 dividend of 15.5 cents per share, partially franked at 60%, maintained
• Final dividend of 7.75 cents per share, payable 21 October 2026
• Operating loss after tax of $125.9 million (FY2025: profit of $219.6 million)
• Investment portfolio declined 10.5% in FY2026, underperforming key ASX indices
• FY2027 dividend target reduced to 8.0 cents per share to preserve capital
• Pre-tax net tangible assets (NTA) at $1.22 per share at 30 June 2026

What else do investors need to know?

The Board’s decision to cut the FY2027 dividend target to 8.0 cents per share comes after years of paying out more in dividends than was earned, drawing down the profits reserve from $1.48 per share to just 5.6 cents per share after the latest payout. The reduction aims to protect WAM Capital’s capital base and rebuild its profits reserve.

In FY2026, WAM Capital’s portfolio underperformed compared to the broader S&P/ASX All Ordinaries Accumulation Index (up 5.7%) and S&P/ASX Small Ordinaries Accumulation Index (up 8.1%). The main challenges were sector positioning and tough conditions for small-cap industrials, as larger companies and AI beneficiaries attracted most investor attention.

WAM Capital remains focused on a diversified portfolio, with notable holdings in Artrya Limited, GemLife Communities, Aussie Broadband, and Maas Group. The investment team has increased cash holdings (11.5% of the portfolio) and repositioned assets looking for better returns in FY2027.

What did WAM Capital management say?

Chairman Geoff Wilson AO said:

Since FY2020, the Board has maintained WAM Capital’s full year dividend at 15.5 cents per share. Over that period, the dividends paid by the Board exceeded the profits generated, drawing down the Company’s accumulated profits reserve. Maintaining the dividend at 15.5 cents per share is no longer sustainable with the profits reserve available.

We recognise the impact a reduction in the FY2027 full year dividend target to 8.0 cents per share will have on shareholders. The FY2027 target is intended to rebuild the profits reserve, preserve the Company’s capital base and place WAM Capital in a stronger position to deliver sustainable income and capital growth for shareholders.

What’s next for WAM Capital?

The Board has set a more sustainable FY2027 dividend target, aiming for 8.0 cents per share, split evenly between interim and final dividends, still partially franked at 60%. Achieving this will depend on generating additional profits through positive portfolio performance in FY2027, so the dividend target is not a formal forecast or guarantee.

Management is optimistic about the potential for recovery, particularly for undervalued smaller companies, as interest rates stabilise and market conditions improve. WAM Capital plans to maintain its active, diversified approach and is positioned to benefit if conditions for small-to-mid-cap stocks pick up.

View Original Announcement

The post WAM Capital trims FY27 dividend after portfolio setback in FY26 appeared first on The Motley Fool Australia.

More reading

• 37 ASX shares going ex-dividend next week
• These 2 ASX shares have given investors a 2026 dividend pay rise
• GemLife beats forecasts and upgrades FY26 guidance
• Aussie Broadband FY26 earnings: double-digit growth and new acquisitions
• Maas Group delivers record FY26 earnings, boosts buybacks, eyes growth

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Aussie Broadband. The Motley Fool Australia has recommended Aussie Broadband. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

Small-cap stocks with growth potential can deliver great share price gains, and Bell Potter thinks they’ve identified two such companies.

They’ve released research reports this week into two companies in the healthcare sector, and are predicting solid gains for both.

Let’s see who they like.

Lumos Diagnostics Ltd (ASX: LDX)

This diagnostic technology company recently reported full-year revenue of US$13.2 million, up 6% on the previous year, and an adjusted EBITDA loss of US$2.8 million, which was a 19% improvement.

The company said it was a “landmark year underpinned by significant regulatory, commercial, and operational achievements that have positioned the Company for future growth”.

The company went on to say:

The year was highlighted by the execution of a transformational six-year U.S. distribution agreement with PHASE Scientific with a value of US$317 million, achievement of U.S. FDA CLIA waiver status for FebriDx, and securing nationwide Medicare reimbursement recognition across all U.S. Medicare Administrative Contractors (MACs). These milestones materially expanded the addressable market opportunity for FebriDx by more than 15 times to over US$1.0 billion per annum and established the foundations for large-scale commercial adoption in the U.S.

The company said FY27 will be about converting the regulatory and commercial milestones achieved in FY26 into sustained revenue growth.

Bell Potter agreed, saying the commercial execution of the FebriDx rollout would be the focus.

The broker is expecting Lumos to hit breakeven in FY29.

Bell Potter has a price target of 25 cents on Lumos, compared to the current price of 10 cents. Lumos Diagnostics is valued at $94.5 million.

Trajan Group Ltd (ASX: TRJ)

This analytical science company delivered second-half EBITDA of $8.1 million, up from $5 million in the first half of the year, but overall full-year earnings were down 14.7%.

Chief Executive Officer Stephen Tomisich said of the result:

FY26 was a year of two halves. While the first quarter created a difficult starting point for the year, the business recovered operationally from Q2 onward, and we delivered a materially stronger second half result. The benefits of Project Neptune and other operational initiatives became increasingly evident in H2, with improved gross margins, stronger nEBITDA and better cost control across the Group. These gains were partly masked in the reported result by the appreciation of the Australian dollar against key trading currencies.

The company’s guidance for the current year is for mid-single-digit organic revenue growth in FY27 and double-digit EBITDA growth.

Bell Potter said the company “is trading at an extremely deep discount, but it will need to turnaround earnings momentum to shift investor sentiment”.

Bell Potter has a price target of 50 cents on Trajan shares compared to 16.5 cents currently.

The post 2 ASX small-cap stocks Bell Potter thinks could return 130% to 200% appeared first on The Motley Fool Australia.

More reading

• Harvey Norman lifts profit and dividend in FY26 earnings result
• WAM Capital trims FY27 dividend after portfolio setback in FY26
• Solstice Minerals extends deep, high-grade copper-gold zones at Nanadie
• Imricor Medical Systems and Philips launch MR-guided cardiac interventions lab
• How much passive income can I earn from $500,000 in superannuation?

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Solstice Minerals Ltd (ASX: SLS) share price is in focus after the company reported outstanding deep drilling results at its 100%-owned Nanadie Copper-Gold Project in Western Australia, including a 722.3-metre intercept grading 0.44% copper and 0.13g/t gold.

What did Solstice Minerals report?

• Confirmed a total intercept of 722.3m @ 0.44% Cu, 0.13g/t Au from hole NANRCD005, extending mineralisation over 500m below the current Mineral Resource boundary.
• Significant high-grade sections include 28m @ 1.31% Cu, 0.30g/t Au and 43.3m @ 0.91% Cu, 0.35g/t Au at depth.
• Current Mineral Resource Estimate (MRE) stands at 40.4 million tonnes @ 0.4% Cu, 0.1g/t Au, with the new results indicating strong potential for expansion.
• Assays are pending from a further 14 diamond holes and over 20 Reverse Circulation (RC) holes.
• Solstice holds $45 million in cash and has no debt, providing a solid balance sheet for continued exploration.
• The Nanadie project sits fully within a granted Mining Lease, with step-up drilling programs underway.

What else do investors need to know?

Solstice Minerals’ drilling campaign is expanding the known copper-gold system well beyond previous boundaries, with both scale and grade persisting at depth. The close match between laboratory assays and previously logged visible copper sulphide zones is increasing confidence in Solstice’s geological model and upcoming drill targets.

The company has invested in expanding its exploration camp and core processing facilities, and expects to have multiple rigs operating for the remainder of the year. Drilling results from the nearby Stark Prospect and unexplored extensions north of Nanadie are also expected to flow through in coming months.

What did Solstice Minerals management say?

Nick Castleden, CEO and Managing Director, said:

NANRCD005 is an extraordinary drillhole that marks another defining moment in the rapidly unfolding story at Nanadie. The combined 722.3m @ 0.44% Cu, 0.13g/t Au intercept – inclusive of all post-mineral dykes and low-grade zones – provides definitive evidence that the deposit will continue to deliver scale and grade way beyond the current MRE limits. Within that broad mineralised envelope, we are seeing multiple substantial higher-grade zones such as 28m @ 1.31% Cu, 0.3g/t Au and 43.3m @ 0.91% Cu, 0.35g/t Au – showing that grade as well as scale persist at depth.

What’s next for Solstice Minerals?

Solstice is stepping up both RC and diamond drilling to test for further extensions of the Nanadie deposit, targeting expansion of its current Mineral Resource. With a second RC rig due onsite and a large volume of assay results still pending, investors can expect a steady news flow through the remainder of 2026.

The business is also planning to drill new prospects at Stark and to test previously untested targets along the broader geological corridor. The focus will remain on growing the scale and grade of the copper-gold system and progressing towards updated resources and potential development studies.

Solstice Minerals share price snapshot

Over the past 12 months, Solstice Minerals shares have surged more than 600%, significantly outpacing the All Ordinaries Index (ASX: XAO).

View Original Announcement

The post Solstice Minerals extends deep, high-grade copper-gold zones at Nanadie appeared first on The Motley Fool Australia.

More reading

• Solstice Minerals: Nanadie drilling extends copper-gold system
• Solstice Minerals: Nanadie copper-gold system grows

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Imricor Medical Systems Inc (ASX: IMR) share price is in focus today after the company announced the commercial launch of its Interventional MR (iMR) lab solution in collaboration with global imaging leader Philips. This new combined solution is immediately available in CE-marked markets and is designed to support MR-guided cardiac interventions.

What did Imricor Medical Systems report?

• Commercial launch of a combined iMR lab solution with Philips.
• The solution integrates Philips’ 1.5T BlueSeal MR platform with Imricor’s NorthStar^®, Advantage-MR^®, and other systems.
• Includes Imricor’s single-use catheters and interventional tools for cardiac procedures.
• Available immediately in CE-marked markets; select configurations in the US now and more pending regulatory approval.
• Scalable platform for potential expansion into new procedures and clinical areas.

What else do investors need to know?

The launch builds on Imricor’s longstanding partnership with Philips, which began in 2012 with joint technology development. The iMR lab solution is designed specifically for cardiac electrophysiology and other interventional cardiac procedures, using MR-guided imaging for improved care.

This innovative, purpose-built approach aims to move MR imaging technology directly into the procedure room, making advanced interventions safer and more effective. The collaboration positions Imricor alongside a major industry player, broadening its reach and potential customer base.

What’s next for Imricor Medical Systems?

Imricor plans to showcase the new iMR lab solution at the ESC Congress 2026 in Munich. The company expects further configurations to be launched in the United States and other geographies as regulatory clearances are achieved.

Management sees this launch as a foundation for future growth, with ambitions to expand the platform into new clinical areas beyond cardiac electrophysiology. The partnership with Philips could pave the way for increased adoption of MR-guided interventions globally.

Imricor Medical Systems share price snapshot

Over the past 12 months, Imricor shares have risen 39%, outperforming the All Ordinaries Index (ASX: XAO).

View Original Announcement

The post Imricor Medical Systems and Philips launch MR-guided cardiac interventions lab appeared first on The Motley Fool Australia.

More reading

• 2 ASX healthcare stocks tipped to return 34% to 63%
• Imricor Medical Systems shares: Philips declares compatibility for iMR products

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

If I were to retire with half a million dollars in superannuation savings, just how much passive income might I expect to earn each year?

It’s a question a lot of Aussies are asking themselves. Whether they’re close to retirement or still have many years to build up their super balance.

And, with history as our guide, the long-term answer is generally the same for folks looking to retire tomorrow or in 30 years.

Now, what we’re interested in here is the annual passive income that you can earn from your superannuation without drawing down on the existing $ 500,000 balance. That way, your income stream doesn’t shrink over time.

How do I create a reliable annual passive income stream?

While there are a few ways you might go about this, in my opinion buying the right basket of ASX dividend shares is the best path to achieving a reliable passive income stream in your golden years.

Atop their dividend payments, we’re also hoping to see some reasonable share price gains over time. Or at least enough to offset the impact of inflation on your superannuation investment and the resulting income stream.

While not written in stone, I’d tend to invest my superannuation savings in the larger end of the market, with stocks listed on the S&P/ASX 200 Index (ASX: XJO). These are normally less volatile than smaller dividend stocks. And you can screen for companies with reliable track records of making two (or more) dividend payouts each year.

I also prefer buying ASX dividend shares with franking credits. These give you credit for the taxes the companies you own have already paid on their profits.

Now, we’ll look at three quality ASX 200 dividend stocks that fit this bill below.

Just take note that the yields you often see are trailing yields. Future yields may be higher or lower depending on a range of company specific and macroeconomic factors.

And, of course, a properly diversified income portfolio will contain more than just three stocks.

With that said…

Investing that $500,000 of superannuation savings

The first quality ASX 200 dividend stock I’d consider buying is Bank of Queensland Ltd (ASX: BOQ).

Over the past 12 months, the ASX 200 bank stock has paid out a total of 55 cents a share in fully franked dividends (including a special dividend). At Thursday’s share price of $6.38, Bank of Queensland shares trade on a fully franked dividend yield of 8.6%.

The second stock I’d consider investing part of my $500,000 of superannuation into is Telstra Group Ltd (ASX: TLS).

Over the past 12 months the ASX 200 telco has paid (or shortly will pay) 21 cents a share in dividends, franked at 90%. At the recent Telstra share price of $4.58, the stock trades on a dividend yield of 4.6%.

And the third ASX 200 stock I’d target with my superannuation savings is Fortescue Ltd (ASX: FMG).

Over the past 12 months, the ASX 200 mining giant has paid (or soon will) a total of $1.08 a share in fully franked dividends. At the recent share price of $17.63, Fortescue shares trade on a fully franked dividend yield of 6.1%.

So, if you were to invest an equal amount of your superannuation savings into each of these three ASX 200 dividend stocks, you could expect to receive an average yield of around 6.4%.

Meaning your half million-dollar investment should see you earning $32,167 a year in passive income without drawing down that super balance.

The post How much passive income can I earn from $500,000 in superannuation? appeared first on The Motley Fool Australia.

More reading

• How much passive income can I earn off a $1 million superannuation balance?
• 37 ASX shares going ex-dividend next week
• How much is needed in superannuation for $2,500 in weekly passive income?
• How much superannuation is needed to target a $50,000 annual passive income?
• How much do I need to retire on $120,000 a year at 55?

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Telstra Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

It has been well documented the headwinds that have hit ASX healthcare shares in recent times. 

Rising interest rates, tighter capital markets, and a more challenging funding environment have weighed heavily on the sector. This has particularly impacted smaller, early-stage companies that remain reliant on external capital to fund growth. 

Yet, beneath the broader weakness, there are signs that the outlook is beginning to improve. Valuations have reset significantly, and a number of quality businesses now offer compelling long-term growth opportunities.

Two that fit this criteria are Mesoblast Ltd (ASX: MSB) and Sigma Healthcare Ltd (ASX: SIG). 

The team at Bell Potter have provided fresh guidance on both ASX healthcare stocks, tipping a big 12 months. 

Here’s what the broker had to say. 

Sigma Healthcare shares looking cheap 

Sigma Healthcare was formed in February 2025 following a merger of the legacy Sigma Healthcare with Chemist Warehouse Group. 

The merger integrates the distribution power of the legacy Sigma business with one of Australia’s most recognised retail pharmacy franchisors. 

In yesterday’s report, Bell Potter said the Chemist Warehouse merger is delivering scale, synergies, and operating leverage. Additionally, the pharmacy business is benefiting from structural growth. 

The broker saw full-year results as broadly in line with expectations, with revenue up 15.5% and normalised EPS rising 22% to 6.3 cents. 

Growth was driven by strong pharmacy sales. Net debt and leverage also improved materially, although most of the leverage reduction came from higher EBITDA rather than lower debt. Overall, Bell Potter sees a business with strong growth and improving efficiency that is now trading at its cheapest valuation since the merger.

Based on this guidance, Bell Potter has a buy recommendation on this ASX healthcare stock and a $3 price target. 

From current levels, this indicates 14% upside. 

Massive upside for Mesoblast 

This ASX healthcare stock has been relatively flat over the last year. 

It is a biotechnology company that develops and commercialises allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care.

The company released annual results yesterday.

Bell Potter said the ASX healthcare company’s results were broadly in line with expectations.

The outlook remains very positive, with Ryoncil expected to deliver continued double-digit growth, and major catalysts ahead from Rexlemestrocel in heart failure and chronic lower back pain. 

The broker has issued a buy recommendation and set a $4.45 price target for this ASX healthcare stock. 

From yesterday’s closing price, this indicates over 84% upside. 

MSB has a long pipeline and label expansions for Ryoncil alone which we expect will come to market on a 3 to 5 year time horizon.

The post Why now is the time to buy low on these ASX healthcare shares with up to 84% upside appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Friday
• Where I’d invest $10,000 in ASX shares in September
• Sigma Healthcare FY26 earnings: Record profit as Chemist Warehouse merger delivers growth
• Mesoblast earnings: Strong revenue growth and operational milestones in FY26
• ASX 200 healthcare shares soar 9% amid notable FY26 reports from CSL, Pro Medicus

Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Weebit Nano Ltd (ASX: WBT) share price is in focus today after the company delivered record revenue of $15.3 million for FY26, up 246% from the prior year, and announced new agreements with major semiconductor players such as Texas Instruments.

What did Weebit Nano report?

• Revenue rose to $15.3 million, up from $4.4 million in FY25.
• Statutory loss after tax increased to $54.9 million (FY25: $38.4 million).
• No dividends declared for the period.
• Net tangible assets per share improved to 63.95 cents (FY25: 43.04 cents).
• Cash balance at 30 June 2026 was $168.3 million, significantly up on the previous year.

What else do investors need to know?

Weebit Nano strengthened its commercial position in FY26 by licensing its ReRAM (Resistive RAM) technology to Texas Instruments, its largest ever customer, and expanded agreements with other key customers. The company also achieved industry-standard technology qualification at foundry partner DB HiTek and demonstrated working chips in collaboration with onsemi.

During the year, the company broadened its leadership team and built up its balance sheet, raising $102 million through capital initiatives. Weebit also established a US subsidiary to support its growing customer base and adoption in North America, and secured a role in Korea’s national In-Memory Compute program, signalling growing recognition for its technology in AI and embedded computing markets.

What did Weebit Nano management say?

Weebit Nano CEO Coby Hanoch said:

Weebit Nano solidified our first mover advantage in embedded ReRAM, delivering significant commercial and technical progress that move us closer to mass production and sets us further apart from competitors… I’m incredibly proud of the world-class team Weebit Nano has built.

What’s next for Weebit Nano?

Looking ahead, Weebit Nano expects continued revenue growth, with at least $7.1 million anticipated in 1H FY27. Management is focusing on supporting customers as they move toward mass production and entering the royalty revenue phase. The group will continue expanding its technology into advanced nodes and invest further in AI-related R&D, especially as demand for efficient memory solutions rises in dynamic markets like AI and automotive.

The company notes ongoing strategic efforts to secure new licensing deals, with an expectation of multiple new agreements over FY27. Weebit Nano’s strong cash position is set to support R&D, commercialisation and new product development.

Weebit Nano share price snapshot

Over the past 12 months, Weebit Nano shares have risen 37%, outpacing the All Ordinaries Index (ASX: XAO).

View Original Announcement

The post Weebit Nano FY26: Record revenue, new customer wins appeared first on The Motley Fool Australia.

More reading

• Why Capstone Copper, Weebit Nano, and Fortescue shares are turning heads on Friday
• Weebit Nano lifts revenue guidance on new deals and chip tape-outs
• 9 ASX 300 shares that tripled in FY26

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Westgold Resources Ltd (ASX: WGX) share price was in focus today after the company reported FY26 revenue soaring 79% to a record $2,441 million, and underlying NPAT of $480 million—up 452% year on year.

What did Westgold Resources report?

• Revenue: $2,441 million, up 79% from FY25
• Underlying NPAT: $480 million, up 452% from FY25
• Underlying EBITDA: $1,104 million at a 45% margin
• Operating cash flow: $964 million, up 170%
• Free cash flow: $602 million, up 11,940% from FY25
• Fully franked dividend: 10 cents per share
• Closing Treasury balance: $939 million

What else do investors need to know?

Westgold produced a record 387,354 ounces of gold during FY26, with strong contributions from its Murchison and Southern Goldfields operations. The company invested approximately $362 million in mine development, exploration, and infrastructure to boost operational flexibility and future production.

The company remained 100% debt free and fully unhedged, while also completing asset divestments, including the Valiant Gold Ltd demerger. Westgold returned $122 million to shareholders via dividends and buybacks, and has approved a further $50 million buy-back for FY27.

What did Westgold Resources management say?

Westgold Resources’ CEO, Wayne Bramwell, commented:

FY26 was a landmark year for Westgold and delivered a strong outcome for shareholders. Record gold production, improved operating consistency and a favourable gold price drove record earnings, cash flow and treasury growth, strengthening our capacity to invest, grow and return capital… Our strategy and value proposition going forward is clear. We have a business of growing scale, balance sheet strength, asset quality and the team to create value while maintaining a clear focus on shareholder returns.

What’s next for Westgold Resources?

Westgold’s board has adopted a new Shareholder Capital Return Policy, supporting ongoing dividends and share buy-backs. Looking ahead, the company will continue to focus on disciplined capital allocation, investing in its largest and most productive assets to boost production and cash flow.

The company will release further updates on its growth strategy and FY27 guidance in the coming weeks, outlining plans for continued production growth and shareholder value creation.

Westgold Resources share price snapshot

The Westgold Resources share price has significantly outperformed the S&P/ASX 200 index (ASX: XJO) over the past 12 months with a gain of 92%.

View Original Announcement

The post Westgold Resources posts record FY26 profit, boosts dividend and returns appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today
• This ASX gold producer could jump by 20%, according to UBS
• 5 things to watch on the ASX 200 on Wednesday
• Westgold Resources launches $100m Meekatharra expansion plan to boost output
• Westgold Resources lifts Ore Reserves by 41% in 2026 update

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The St Barbara Ltd (ASX: SBM) share price is in focus today as the gold miner revealed a statutory profit after tax of $490 million for FY26 and announced a fully franked dividend of 5 cents per share.

What did St Barbara report?

• Statutory profit after tax of A$490 million, up from a loss of A$94 million in FY25
• Revenue from ordinary activities (continuing operations) down 76% to A$3.6 million
• Net assets increased 148% to A$928 million by 30 June 2026
• Cash position of A$475 million with no debt or hedging
• Fully franked final dividend of 5 cents per share declared, payable 16 October 2026
• EBITDA (excluding significant items) loss of A$18 million

What else do investors need to know?

St Barbara’s strong result was largely driven by a A$500 million gain on the deconsolidation of New Simberi Gold, following a major strategic investment by Lingbao Gold Group. This transaction saw St Barbara reduce its ownership in New Simberi Gold to 50% minus one share, making it an investment in associate rather than a controlled entity.

The company reported New Simberi Gold generated an underlying profit of A$40 million for the first nine months, compared to a A$30 million loss in FY25. The board also announced the transfer of A$355 million of FY26 statutory profit to a distributable reserve, supporting the dividend payment.

Additionally, St Barbara is considering an on-market share buy-back of up to 100 million shares, with a final decision expected after an update to the 15-Mile Processing Hub Project Pre-Feasibility Study later in 2026.

What did St Barbara management say?

Managing Director and CEO Andrew Strelein commented:

FY26 was a breakthrough year for St Barbara. We completed the Lingbao strategic investment, secured the funding and early mining lease renewal for FID on the New Simberi Gold Expansion Project, completed permitting and FID for the Touquoy Restart and we delivered a compelling 15-Mile Processing Hub Project Pre-Feasibility Study.

The strengthened balance sheet and healthy funding position has enabled the Board to declare a fully franked dividend of A$0.05 per share. The Company is also considering an on-market share buy-back of up to 100 million shares but will delay a decision until we have been able to announce the results of the update to the 15-Mile Processing Hub Project Pre-Feasibility Study, which is anticipated to be released at the end of September.

The Company is committed to prudent capital discipline and will take the opportunity to pass on the available franked dividends as quickly as the balance sheet and funding outlook permits. St Barbara enters FY27 focused on value creation for shareholders, through project delivery, operational performance and efficient capital management.

What’s next for St Barbara?

Looking ahead, St Barbara intends to remain focused on project delivery and capital management following its recapitalisation and strategic partnership with Lingbao. The board expects to decide on a potential share buy-back after the release of further details on the 15-Mile Processing Hub Project.

The New Simberi Gold Expansion Project and the Touquoy Restart in Canada are both moving forward, with St Barbara highlighting sustainable value creation for shareholders as a top priority for FY27.

St Barbara share price snapshot

Over the past year, the St Barbara shares have risen 84%, significantly outpacing the All Ordinaries Index (ASX: XAO).

View Original Announcement

The post St Barbara posts $490m profit and declares 5¢ dividend for FY26 appeared first on The Motley Fool Australia.

More reading

• St Barbara ramps up Nova Scotia exploration spend in FY27
• Up 61% in a year, why is this ASX 300 gold stock getting hammered on Thursday?
• St Barbara FY26 Q4: Cash builds as growth projects advance

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.